The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Proinflammatory Cytokines and Early Neurological Worsening in Ischemic Stroke
Open accessAbstract
Background and Purpose —The mechanisms for clinical deterioration in patients with ischemic stroke are not completely understood. Several proinflammatory cytokines are released early after the onset of brain ischemia, but it is unknown whether inflammation predisposes to neurological deterioration. We assessed the implication of interleukin (IL)-6 and tumor necrosis factor (TNF)-α in early neurological worsening in ischemic stroke. Methods —Two hundred thirty-one patients consecutively admitted with first-ever ischemic cerebral infarction within the first 24 hours from onset were included. Neurological worsening was defined when the Canadian Stroke Scale (CSS) score fell at least 1 point during the first 48 hours after admission. IL-6 and TNF-α were determined in plasma and cerebrospinal fluid (CSF; n=81) obtained on admission. Results —Eighty-three patients (35.9%) deteriorated within the first 48 hours. IL-6 in plasma (>21.5 pg/mL; OR 37.7, CI 11.9 to 118.8) or in CSF (>6.3 pg/mL; OR 13.1, CI 2.2 to 77.3) were independent factors for early clinical worsening, with multiple logistic regression. The association was statistically significant in all ischemic stroke subtypes as well as in subjects with cortical or subcortical infarctions. IL-6 in plasma was highly correlated with body temperature, glucose, fibrinogen, and infarct volume. CSF and plasma concentrations of TNF-α were also higher in patients who deteriorated, but the differences observed did not remain significant on multivariate analysis. Conclusions —In addition to participating in the acute-phase response that follows focal cerebral ischemia, IL-6 levels on admission are associated with early clinical deterioration. The association between IL-6 and early neurological worsening prevails without regard to the initial size, topography, or mechanism of the ischemic infarction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adams, H. P., Bendixen, B. H., Kappelle, L. J., Biller, J., Love, B. B., Gordon, D. L., & Marsh, E. E. (1993) · Stroke · doi:10.1161/01.str.24.1.35 · Cited by 12,335
Tumor Necrosis Factor-α: A Mediator of Focal Ischemic Brain Injury
Barone, F. C., Arvin, B., White, R. F., Miller, A., Webb, C. L., Willette, R. N., Lysko, P. G., & Feuerstein, G. Z. (1997) · Stroke · doi:10.1161/01.str.28.6.1233 · Cited by 863
del Zoppo, G. J., Schmid-Schönbein, G. W., Mori, E., Copeland, B. R., & Chang, C. M. (1991) · Stroke · doi:10.1161/01.str.22.10.1276 · Cited by 765
Kochanek, P. M., & Hallenbeck, J. M. (1992) · Stroke · doi:10.1161/01.str.23.9.1367 · Cited by 615
Nawroth, P. P., Handley, D. A., Esmon, C. T., & Stern, D. M. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.10.3460 · Cited by 582
Interleukin-1 as a Pathogenetic Mediator of Ischemic Brain Damage in Rats
Yamasaki, Y., Matsuura, N., Shozuhara, H., Onodera, H., Itoyama, Y., & Kogure, K. (1995) · Stroke · doi:10.1161/01.str.26.4.676 · Cited by 572
Early Intrathecal Production of Interleukin-6 Predicts the Size of Brain Lesion in Stroke
Tarkowski, E., Rosengren, L., Blomstrand, C., Wikkelsö, C., Jensen, C., Ekholm, S., & Tarkowski, A. (1995) · Stroke · doi:10.1161/01.str.26.8.1393 · Cited by 383
The Canadian Neurological Scale: a preliminary study in acute stroke.
Côté, R., Hachinski, V. C., Shurvell, B. L., Norris, J. W., & Wolfson, C. (1986) · Stroke · doi:10.1161/01.str.17.4.731 · Cited by 341
Fassbender, K., Rossol, S., Kammer, T., Daffertshofer, M., Wirth, S., Dollman, M., & Hennerici, M. (1994) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(94)90289-5 · Cited by 325
Effect of blood pressure and diabetes on stroke in progression
Jørgensen, H. S., Nakayama, H., Olsen, T. S., & Raaschou, H. O. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92757-x · Cited by 322
Cited by
Inflammatory mechanisms in ischemic stroke: therapeutic approaches
Lakhan, S. E., Kirchgessner, A., & Hofer, M. (2009) · Journal of Translational Medicine · doi:10.1186/1479-5876-7-97 · Cited by 1,072
Central nervous system injury-induced immune deficiency syndrome
Meisel, C., Schwab, J. M., Prass, K., Meisel, A., & Dirnagl, U. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1765 · Cited by 968
Neuroinflammatory mechanisms of blood-brain barrier damage in ischemic stroke
Yang, C., Hawkins, K. E., Doré, S., & Candelario-Jalil, E. (2019) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00136.2018 · Cited by 871
Inflammatory Cytokines in Experimental and Human Stroke
Lambertsen, K. L., Biber, K., & Finsen, B. (2012) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2012.88 · Cited by 732
The immunology of acute stroke
Chamorro, Á., Meisel, A., Planas, A. M., Urra, X., van de Beek, D., & Veltkamp, R. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.98 · Cited by 707
Toll-Like Receptor 4 Is Involved in Brain Damage and Inflammation After Experimental Stroke
Caso, J. R., Pradillo, J. M., Hurtado, O., Lorenzo, P., Moro, M. A., & Lizasoain, I. (2007) · Circulation · doi:10.1161/circulationaha.106.603431 · Cited by 606
The complexity of neurobiological processes in acute ischemic stroke
Brouns, R., & De Deyn, P. P. (2009) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2009.04.001 · Cited by 526
Jurcau, A., & Simion, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010014 · Cited by 500
Smith, C. J., Emsley, H. C., Gavin, C. M., Georgiou, R. F., Vail, A., Barberan, E. M., del Zoppo, G. J., Hallenbeck, J. M., Rothwell, N. J., Hopkins, S. J., et al. (2004) · BMC Neurology · doi:10.1186/1471-2377-4-2 · Cited by 480
Hyperglycemia in acute ischemic stroke: pathophysiology and clinical management
Kruyt, N. D., Biessels, G. J., DeVries, J. H., & Roos, Y. B. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.231 · Cited by 386
ANISMAN, H., MERALI, Z., & HAYLEY, S. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.01.004 · Cited by 337
Pathogenesis of acute stroke and the role of inflammasomes
Fann, D. Y.-W., Lee, S.-Y., Manzanero, S., Chunduri, P., Sobey, C. G., & Arumugam, T. V. (2013) · Ageing Research Reviews · doi:10.1016/j.arr.2013.09.004 · Cited by 335
Inflammatory Markers and Incident Mobility Limitation in the Elderly
Penninx, B. W. J. H., Kritchevsky, S. B., Newman, A. B., Nicklas, B. J., Simonsick, E. M., Rubin, S., Nevitt, M., Visser, M., Harris, T., & Pahor, M. (2004) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2004.52308.x · Cited by 326
Tang, Y., Xu, H., Du, X. L., Lit, L., Walker, W., Lu, A., Ran, R., Gregg, J. P., Reilly, M., Pancioli, A., et al. (2006) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600264 · Cited by 326
Elevation of Tumor Necrosis Factor-Alpha in Cerebrospinal Fluid of Autistic Children
Chez, M. G., Dowling, T., Patel, P. B., Khanna, P., & Kominsky, M. (2007) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2007.01.012 · Cited by 317
Emsley, H. (2003) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(03)00134-6 · Cited by 301
Functional differences between microglia and monocytes after ischemic stroke
Ritzel, R. M., Patel, A. R., Grenier, J. M., Crapser, J., Verma, R., Jellison, E. R., & McCullough, L. D. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0329-1 · Cited by 295
“Inflammation is a key component of stroke-induced injury and elevated levels of inflammatory markers are associated with poor outcome in stroke patients [1–4].”
BackgroundMarkus, H. S. (2004) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2003.025825 · Cited by 293
Spalletta, G., Bossù, P., Ciaramella, A., Bria, P., Caltagirone, C., & Robinson, R. G. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001879 · Cited by 290
Blood Markers for the Prognosis of Ischemic Stroke: A Systematic Review
Whiteley, W., Chong, W. L., Sengupta, A., & Sandercock, P. (2009) · Stroke · doi:10.1161/strokeaha.108.528752 · Cited by 290
Levels of Anti-Inflammatory Cytokines and Neurological Worsening in Acute Ischemic Stroke
Vila, N., Castillo, J., Dávalos, A., Esteve, A., Planas, A. M., & Chamorro, A. (2003) · Stroke · doi:10.1161/01.str.0000057976.53301.69 · Cited by 282
Self-citationKlehmet, J., Harms, H., Richter, M., Prass, K., Volk, H. D., Dirnagl, U., Meisel, A., & Meisel, C. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2008.07.044 · Cited by 281
Changes in cerebrospinal fluid levels of pro-inflammatory cytokines in CRPS
Alexander, G. M., van Rijn, M. A., van Hilten, J. J., Perreault, M. J., & Schwartzman, R. J. (2005) · Pain · doi:10.1016/j.pain.2005.04.013 · Cited by 280
Inflammation and Infection in Clinical Stroke
Emsley, H. C. A., & Tyrrell, P. J. (2002) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200212000-00001 · Cited by 276
Ayata, C., & Ropper, A. H. (2002) · Journal of Clinical Neuroscience · doi:10.1054/jocn.2001.1031 · Cited by 275
Molecular signatures of brain injury after intracerebral hemorrhage
Castillo, J., Dávalos, A., Álvarez–Sabín, J., Pumar, J. M., Leira, R., Silva, Y., Montaner, J., & Kase, C. S. (2002) · Neurology · doi:10.1212/wnl.58.4.624 · Cited by 274
Self-citationNeuroinflammation and Cerebrovascular Disease in Old Age: A Translational Medicine Perspective
Di Napoli, M., & Shah, I. M. (2011) · Journal of Aging Research · doi:10.4061/2011/857484 · Cited by 263
Suzuki, S., Brown, C. M., Dela Cruz, C. D., Yang, E., Bridwell, D. A., & Wise, P. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610394104 · Cited by 256
Elkind, M. S. V., Tai, W., Coates, K., Paik, M. C., & Sacco, R. L. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.19.2073 · Cited by 255
Plasma and Cerebrospinal Fluid Interleukin-6 Concentrations in Posttraumatic Stress Disorder
Baker, D. G., Ekhator, N. N., Kasckow, J. W., Hill, K. K., Zoumakis, E., Dashevsky, B. A., Chrousos, G. P., & Geracioti Jr., T. D. (2001) · Neuroimmunomodulation · doi:10.1159/000049028 · Cited by 238
Expression of cytokines and cytokine receptors in the rat brain after kainic acid-induced seizures
Lehtimäki, K. A., Peltola, J., Koskikallio, E., Keränen, T., & Honkaniemi, J. (2003) · Molecular Brain Research · doi:10.1016/s0169-328x(02)00654-x · Cited by 163
Martino, M., Rocchi, G., Escelsior, A., & Fornaro, M. (2012) · Current Neuropharmacology · doi:10.2174/157015912800604542 · Cited by 111
“Levels of IL-6 in the serum of acute stroke patients have been reported to also correlate with stroke severity; serum concentrations of IL-6, IL-8 and IL-10 were higher in asphyxiated neonates; while cerebral ischemia initiates a Th1-prevalent inflammatory response associated with induction of a variety of cytokines,…”
BackgroundEvidence that Meningeal mast cells can worsen stroke pathology in mice.
Arac, A., Grimbaldeston, M. A., Nepomuceno, A. R. B., Olayiwola, O., Pereira, M. P., Nishiyama, Y., Tsykin, A., Goodall, G. J., Schlecht, U., Vogel, H., et al. (2014) · The American Journal of Pathology · doi:10.1016/j.ajpath.2014.06.003 · Cited by 74
Marín-Prida, J., Pavón-Fuentes, N., Llópiz-Arzuaga, A., Fernández-Massó, J. R., Delgado-Roche, L., Mendoza-Marí, Y., Santana, S. P., Cruz-Ramírez, A., Valenzuela-Silva, C., Nazábal-Gálvez, M., et al. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.05.021 · Cited by 61
Öztürk, C., Özge, A., Yalın, O. Ö., Yılmaz, İ. A., Delialioglu, N., Yıldız, Ç., Tesdelen, B., & Kudiaki, C. (2007) · Behavioural Neurology · doi:10.1155/2007/432190 · Cited by 46
Tian, Y., Wang, L., Fan, X., Zhang, H., Dong, Z., & Tao, T. (2023) · PLOS ONE · doi:10.1371/journal.pone.0279964 · Cited by 21
Metadata
- Authors
- Vila, N., Castillo, J., Dávalos, A., & Chamorro, A.
- Venue
- Stroke
- Published
- 2000-10
- Volume
- 31
- Issue
- 10
- Pages
- 2325-2329
- ISSN
- 0039-2499 (ISSN-L)
- 1524-4628
- OpenAlex
- W2132401640
- Cited by
- 675
- References
- 27
- FWCI
- 14.42
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.